SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
Sodium‐glucose co-transporter 2 (SGLT2) inhibitors have recently emerged as an effective means to protect kidney function in people with type 2 diabetes and chronic kidney disease (CKD). In this review, we explore the role of SGLT2 inhibition in these individuals. SGLT2 inhibitors specifically act t...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Revisão |
| Хэл сонгох: | англи |
| Хэвлэсэн: |
2023
|
| Онлайн хандалт: | https://doi.org/10.1530/ec-23-0005 https://ec.bioscientifica.com/downloadpdf/journals/ec/aop/ec-23-0005/ec-23-0005.pdf |
| Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|